TCM
ALNY icon

Traynor Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Traynor Capital Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.98M Buy
12,592
+1,022
+9% +$348K 0.24% 66
2025
Q4 		$4.6M Buy
11,570
+697
+6% +$308K 0.25% 60
2025
Q3 		$4.96M Buy
10,873
+668
+7% +$272K 0.28% 54
2025
Q2 		$3.29M Buy
10,205
+372
+4% +$103K 0.23% 55
2025
Q1 		$2.66M Buy
9,833
+483
+5% +$124K 0.22% 65
2024
Q4 		$2.2M Buy
9,350
+2,101
+29% +$553K 0.17% 78
2024
Q3 		$1.99M Buy
+7,249
New +$1.89M 0.16% 79
2017
Q3 		– Sell
-6,479
Closed -$516K – 169
2017
Q2 		$516K Buy
6,479
+1,200
+23% +$76.7K 0.25% 81
2017
Q1 		$280K Buy
+5,279
New +$244K 0.16% 116

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return